ERDAFITINIB FOR INTRAVESICAL ADMINISTRATION FOR USE IN THE TREATMENT OF BLADDER CANCER
Provided herein are methods of treatment, erdafitinib for use and use of erdafitinib for the treatment of bladder cancer harboring one or more FGFR alterations comprising locally delivering erdafitinib into the bladder of a patient. L'invention concerne des méthodes de traitement, l'erdafi...
Saved in:
Main Authors | , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
22.08.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided herein are methods of treatment, erdafitinib for use and use of erdafitinib for the treatment of bladder cancer harboring one or more FGFR alterations comprising locally delivering erdafitinib into the bladder of a patient.
L'invention concerne des méthodes de traitement, l'erdafitinib à des fins d'utilisation et l'utilisation d'erdafitinib pour le traitement du cancer de la vessie hébergeant une ou plusieurs altérations du FGFR, comprenant la délivrance locale d'erdafitinib dans la vessie d'un patient. |
---|---|
Bibliography: | Application Number: WO2024US15572 |